10 Biogen business development leaders
These Biogen business development leaders hold senior vice president, executive director, head, senior director and director titles in business development, M&A, external innovation and alliance management. A reader can learn how business development leaders work at Biogen from people who have held the role.
Professionals to explore
Adam L. Feire
LinkedInExperience: SVP, Head of Business Development/M&A, and External Innovation · Biogen
Adam L. Feire has been SVP, Head of Business Development/M&A, and External Innovation at Biogen since September 2024. At Novartis, Adam L. Feire was Global Head Search & Evaluation, Corporate & Business Development (2023–2024), Global Head Search & Evaluation, Innovative Medicines (2022–2023), Head of Search & Evaluation, North America, Business Development & Licensing (2020–2022) and Executive Director, Search & Evaluation, Business Development & Licensing (2019–2020).
Adriana I Larriera
LinkedInExperience: Senior Director, Corporate Development, Alliance Management · Biogen
Adriana I Larriera has been Senior Director, Corporate Development, Alliance Management at Biogen since October 2024. Adriana I Larriera was Principal/ Director, Strategic Advisory at Trinity Life Sciences (2022–2024), and at Biogen was Director, NMD Early Commercialization Strategy (2021–2022) and Associate Director, MS Marketing, West Division (2019–2021).
Amita Joshi
LinkedInExperience: Director, Alliance Management · Biogen
Amita Joshi has been Director, Alliance Management at Biogen since April 2025. Amita Joshi was Senior Director Alliance Management at Intellia Therapeutics, Inc. (2021–2025), and at Sanofi was Director, Strategic Initiatives & Scientific Relations (2018–2021) and Director, Alliance Management (2017–2018).
Inna Nusinzon
LinkedInExperience: Senior Director, Business Development and M&A · Biogen
Inna Nusinzon has been Senior Director, Business Development and M&A at Biogen since July 2022. Inna Nusinzon was Director, Business Development Oncology at GSK (2019–2022), Senior Manager, Business Development at TESARO, Inc. (2017–2019), and worked in Business Development and Licensing at Dana-Farber Cancer Institute (2013–2017).
Kevin Bromby
LinkedInExperience: Executive Director, Transactions Lead - Business Development, M&A and New Ventures · Biogen
Kevin Bromby has been Executive Director, Transactions Lead - Business Development, M&A and New Ventures at Biogen since September 2025. At Biogen, Kevin Bromby was also Senior Director, Head of Corporate Transactions (M&A and Business Development) (2023–2025), Director, Business Development and M&A (2020–2023) and Associate Director, Corporate Transactions (M&A and Business Development) (2019–2020).
Martina Wagemann
LinkedInExperience: Sr Director Alliance Management · Biogen
Martina Wagemann has been Sr Director Alliance Management at Biogen since September 2026, and the profile also lists Global Program & Alliance Management Director, Corporate Development at Biogen from October 2021. At Amgen, Martina Wagemann held marketing, alliance and integration roles (2017–2021).
Neel Desai
LinkedInExperience: Former Executive Director, Business Development & Licensing · Biogen
Former Executive Director, Business Development & Licensing at Biogen (2018–2025). Neel Desai has worked in Business Development at NRE since February 2026, and was Vice President, Head of Business Development at Piramal Pharma Ltd (2012–2017) and Associate Director, Corporate Strategy at AstraZeneca (2011–2012).
Patrycja Tracz
LinkedInExperience: Director, Alliance Management and Corporate Development · Biogen
Patrycja Tracz has been Director, Alliance Management and Corporate Development at Biogen since November 2024, and was Associate Director, Alliance Management and Corporate Development there (2020–2024). Patrycja Tracz was Associate Director, Marketing, US Oncology at Servier Pharmaceuticals (2018–2020) and Senior Product Manager, US Oncology at Shire (2016–2018).
Tyler Ash
LinkedInExperience: Director, Business Development - Transactions · Biogen
Tyler Ash has been Director, Business Development - Transactions at Biogen since April 2026. At Biogen, Tyler Ash was also Associate Director Business Development (2023–2026), Senior Manager, Business Development (2022–2023) and Senior Manager, R&D Finance (2020–2022), and was Corporate Development Manager at Abcam (2019–2020).
Yves Wyckmans
LinkedInExperience: Head International Business Development and External Innovation · Biogen
Yves Wyckmans has been Head International Business Development and External Innovation at Biogen since September 2025. At Johnson & Johnson Innovative Medicine, Yves Wyckmans was Senior Director, Business Development and Alliance management, Pulmonary and Cardio Vascular (2018–2025) and Senior Director, Business Development and Alliance Management, Immunology and Oncology (2014–2018).
Choose the right perspective
Pick someone with a transactions or M&A title for questions about structuring a deal, and someone from alliance management for questions about running a partnership after signing. Ask about the years the person held the role, since business development priorities can change from one period to the next.
Questions to take into the conversation
- 01How does a biotech business development group decide between licensing a program and acquiring a company?
- 02What does alliance management involve once a biotech signs a collaboration?
- 03How does a transactions team work with research and commercial teams when evaluating an outside asset?
Reaching Biogen business development leaders
How can I contact one of these Biogen business development leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Biogen, based on profile data retrieved on October 26, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Biogen business development leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Biogen business development leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.